- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Stem Cells International
Volume 2011 (2011), Article ID 943216, 10 pages
Could Metabolic Syndrome, Lipodystrophy, and Aging Be Mesenchymal Stem Cell Exhaustion Syndromes?
1Tissue Engineering, Regenerative Medicine and Cell Therapies Laboratory, CUCAIBA, Ministry of Health, Province of Buenos Aires, 1900 La Plata, Argentina
2Lipid Clinic, Division of Endocrinology, Hospital Clinic, 08036 Barcelona, Spain
3Division of Endometrial Regenerative Stem Cells, Medistem Inc., San Diego, CA 92122, USA
4Division of Cardiothoracic Surgery, University of Utah, Salt Lake City, UT 84132, USA
5Division Skin Bank, Burns Hospital, Buenos Aires City, C1424BSD, Argentina
6LNK Chemsolutions, Division of Nanotechnology, Lincoln, NE 68521, USA
7Bio-Target, Division of Nanotechnology, NE 68339, USA
8The University of Chicago, Division of Nanotechnology, Chicago, IL 60637, USA
9Nanovogue Inc., Division of Intelligent Matrices, Chicago, IL 60126-2731, USA
10INCUCAI, Presidency, Ministry of Health, 2250-C1428BAJ Buenos Aires, Argentina
11Vrije Universiteit, Burns Division, 1081 HV Amsterdam, The Netherlands
Received 15 August 2010; Accepted 22 March 2011
Academic Editor: Jozef Bartunek
Copyright © 2011 Eduardo Mansilla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- I. Saito, H. Iso, Y. Kokubo, M. Inoue, and S. Tsugane, “Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study,” Circulation Journal, vol. 73, no. 5, pp. 878–884, 2009.
- P. Zimmet and G. Alberti, “The metabolic syndrome: progress towards one definition for an epidemic of our time,” Nature Clinical Practice Endocrinology and Metabolism, vol. 4, no. 5, p. 239, 2008.
- G. M. Reaven, “The metabolic syndrome: requiescat in Pace,” Clinical Chemistry, vol. 51, no. 6, pp. 931–938, 2005.
- M. A. Pappolla, T. K. Bryant-Thomas, D. Herbert et al., “Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology,” Neurology, vol. 61, no. 2, pp. 199–205, 2003.
- M. Junyent, R. Gilabert, E. Jarauta et al., “Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia,” Atherosclerosis, vol. 208, no. 2, pp. 437–441, 2010.
- R. Ceska, “Clinical implications of the metabolic syndrome,” Diabetes and Vascular Disease Research, vol. 4, no. 3, pp. S2–S4, 2007.
- P. Zimmet, D. Magliano, Y. Matsuzawa, G. Alberti, and J. Shaw, “The metabolic syndrome: a global public health problem and a new definition,” Journal of Atherosclerosis and Thrombosis, vol. 12, no. 6, pp. 295–300, 2005.
- J. Capeau, “From lipodystrophy and insulin resistance to metabolic syndrome: HIV infection, treatment and aging,” Current Opinion in HIV and AIDS, vol. 2, no. 4, pp. 247–252, 2007.
- P. W. Stacpoole, J. Alig, L. L. Kilgore et al., “Lipodystrophic diabetes mellitus. Investigations of lipoprotein metabolism and the effects of omega-3 fatty acid administration in two patients,” Metabolism: Clinical and Experimental, vol. 37, no. 10, pp. 944–951, 1988.
- J. Capeau, J. Magré, O. Lascols et al., “Diseases of adipose tissue: genetic and acquired lipodystrophies,” Biochemical Society Transactions, vol. 33, no. 5, pp. 1073–1077, 2005.
- K. A. Lichtenstein, “Redefining lipodystrophy syndrome: risks and impact on clinical decision making,” Journal of Acquired Immune Deficiency Syndromes, vol. 39, no. 4, pp. 395–400, 2005.
- V. Simha and A. Garg, “Inherited lipodystrophies and hypertriglyceridemia,” Current Opinion in Lipidology, vol. 20, no. 4, pp. 300–308, 2009.
- J. Capeau, C. Vigouroux, J. Magré, O. Lascols, M. Caron, and J. P. Bastard, “Lipodystrophic syndromes: congenital or acquired diseases of adipose tissue,” Comptes Rendus - Biologies, vol. 329, no. 8, pp. 639–652, 2006.
- E. Urich, “Insulin resistance: the adipose tissue in the focus,” Orvosi Hetilap, vol. 146, no. 43, pp. 2199–2207, 2005.
- S. Virtue and A. Vidal-Puig, “Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome—an allostatic perspective,” Biochimica et Biophysica Acta, vol. 1801, no. 3, pp. 338–349, 2010.
- E. Arner, P. O. Westermark, K. L. Spalding et al., “Adipocyte turnover: relevance to human adipose tissue morphology,” Diabetes, vol. 59, no. 1, pp. 105–109, 2010.
- T. T. Tran and C. R. Kahn, “Transplantation of adipose tissue and stem cells: role in metabolism and disease,” Nature Reviews Endocrinology, vol. 6, no. 4, pp. 195–213, 2010.
- S. Perrini, A. Cignarelli, R. Ficarella, L. Laviola, and F. Giorgino, “Human adipose tissue precursor cells: a new factor linking regulation of fat mass to obesity and type 2 diabetes?” Archives of Physiology and Biochemistry, vol. 115, no. 4, pp. 218–226, 2009.
- K. W. Park, D. S. Halperin, and P. Tontonoz, “Before they were fat: adipocyte progenitors,” Cell Metabolism, vol. 8, no. 6, pp. 454–457, 2008.
- K. M. Hong, M. D. Burdick, R. J. Philips, D. Heber, and R. M. Strieter, “Characterization of human fibrocytes as circulating adipocyte progenitors and the formation of human adipose tissue in SCID mice,” FASEB Journal, vol. 19, no. 14, pp. 2029–2031, 2005.
- S. Cinti, “Adipocyte differentiation and transdifferentiation: plasticity of the adipose organ,” Journal of Endocrinological Investigation, vol. 25, no. 10, pp. 823–835, 2002.
- S. S. Tholpady, A. J. Katz, and R. C. Ogle, “Mesenchymal stem cells from rat visceral fat exhibit multipotential differentiation in vitro,” Anatomical Record, Part A, vol. 272, no. 1, pp. 398–402, 2003.
- M. Laudes, “Role of WNT signalling in the determination of human mesenchymal stem cells into preadipocytes,” Journal of Molecular Endocrinology, vol. 46, no. 2, pp. R65–R72, 2011.
- S. S. Hei, “Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate,” Molecular Endocrinology, vol. 23, no. 11, pp. 1717–1725, 2009.
- P. A. Zuk, M. Zhu, P. Ashjian et al., “Human adipose tissue is a source of multipotent stem cells,” Molecular Biology of the Cell, vol. 13, no. 12, pp. 4279–4295, 2002.
- H. Mizuno, Y. Itoi, S. Kawahara, R. Ogawa, S. Akaishi, and H. Hyakusoku, “In vivo adipose tissue regeneration by adipose-derived stromal cells isolated from GFP transgenic mice,” Cells Tissues Organs, vol. 187, no. 3, pp. 177–185, 2008.
- C. Elabd, C. Chiellini, M. Carmona et al., “Human multipotent adipose-derived stem cells differentiate into functional brown adipocytes,” Stem Cells, vol. 27, no. 11, pp. 2753–2760, 2009.
- W. Tang, D. Zeve, J. M. Suh et al., “White fat progenitor cells reside in the adipose vasculature,” Science, vol. 322, no. 5901, pp. 583–586, 2008.
- S. M. Majka, K. E. Fox, J. C. Psilas et al., “De novo generation of white adipocytes from the myeloid lineage via mesenchymal intermediates is age, adipose depot, and gender specific,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 33, pp. 14781–14786, 2010.
- T. J. Schulz, T. L. Huang, T. T. Tran et al., “Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 1, pp. 143–148, 2011.
- D. Langin, “Recruitment of brown fat and conversion of white into brown adipocytes: strategies to fight the metabolic complications of obesity?” Biochimica et Biophysica Acta, vol. 1801, no. 3, pp. 372–376, 2010.
- J. A. Timmons and B. K. Pedersen, “The importance of brown adipose tissue,” New England Journal of Medicine, vol. 361, no. 4, pp. 415–416, 2009.
- H. A. Jacene and R. L. Wahl, “The importance of brown adipose tissue,” New England Journal of Medicine, vol. 361, no. 4, pp. 417–418, 2009.
- D. L. Morganstein, P. Wu, M. R. Mane, N. M. Fisk, R. White, and M. G. Parker, “Human fetal mesenchymal stem cells differentiate into brown and white adipocytes: a role for ERRα in human UCP1 expression,” Cell Research, vol. 20, no. 4, pp. 434–444, 2010.
- S. Shah, J. Ulm, Z. C. Sifri, A. M. Mohr, and D. H. Livingston, “Mobilization of bone marrow cells to the site of injury is necessary for wound healing,” Journal of Trauma, vol. 67, no. 2, pp. 315–321, 2009.
- T. Glaros, M. Larsen, and L. Li, “Macrophages and fibroblasts during inflammation, tissue damage and organ injury,” Frontiers in Bioscience, vol. 14, pp. 3988–3993, 2009.
- I. Jialal, G. P. Fadini, K. Pollock, and S. Devaraj, “Circulating levels of endothelial progenitor cell mobilizing factors in the metabolic syndrome,” American Journal of Cardiology, vol. 106, no. 11, pp. 1606–1608, 2010.
- G. L. Hoetzer, G. P. Van Guilder, H. M. Irmiger, R. S. Keith, B. L. Stauffer, and C. A. DeSouza, “Aging, exercise, and endothelial progenitor cell clonogenic and migratory capacity in men,” Journal of Applied Physiology, vol. 102, no. 3, pp. 847–852, 2007.
- G. P. Fadini, S. V. De Kreutzenberg, A. Coracina et al., “Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk,” European Heart Journal, vol. 27, no. 18, pp. 2247–2255, 2006.
- C. M. Kolf, E. Cho, and R. S. Tuan, “Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation,” Arthritis Research and Therapy, vol. 9, no. 1, article no. 204, 2007.
- Y. Shi, G. Hu, J. Su et al., “Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair,” Cell Research, vol. 20, no. 5, pp. 510–518, 2010.
- S. W. Qian, XI. Li, Y. Y. Zhang et al., “Characterization of adipocyte differentiation from human mesenchymal stem cells in bone marrow,” BMC Developmental Biology, vol. 10, article no. 47, 2010.
- C. De Bari, F. Dell'Accio, J. Vanlauwe et al., “Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis,” Arthritis and Rheumatism, vol. 54, no. 4, pp. 1209–1221, 2006.
- E. Mansilla, H. Drago, G. H. Marin, F. Sturla, R. Ibar, and C. Soratti, “Mesenchymal stem cells, could they be the link between tolerance and regeneration?” Burns, vol. 33, no. 2, pp. 137–138, 2007.
- J. A. Kode, S. Mukherjee, M. V. Joglekar, and A. A. Hardikar, “Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration,” Cytotherapy, vol. 11, no. 4, pp. 377–391, 2009.
- C. A. Gregory, J. Ylostalo, and D. J. Prockop, “Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental “niches” in culture: a two-stage hypothesis for regulation of MSC fate,” Science's STKE, vol. 2005, no. 294, p. pe37, 2005.
- N. Carlesso and A. A. Cardoso, “Stem cell regulatory niches and their role in normal and malignant hematopoiesis,” Current Opinion in Hematology, vol. 17, no. 4, pp. 281–286, 2010.
- Z. Zhong, A. N. Patel, T. E. Ichim et al., “Feasibility investigation of allogeneic endometrial regenerative cells,” Journal of Translational Medicine, vol. 7, article no. 15, 2009.
- G. Q. Jia, M. M. Zhang, P. Yang, J. Q. Cheng, Y. R. Lu, and X. T. Wu, “Effects of the different culture and isolation methods on the growt, Proliferation and biology characteristics of rat bone marrow mesenchymal stem cells,” Sichuan Da Xue Xue Bao Yi Xue Ban, vol. 40, no. 4, pp. 719–723, 2009.
- L. da Silva Meirelles, P. C. Chagastelles, and N. B. Nardi, “Mesenchymal stem cells reside in virtually all post-natal organs and tissues,” Journal of Cell Science, vol. 119, no. 11, pp. 2204–2213, 2006.
- A. Chapel, J. M. Bertho, M. Bensidhoum et al., “Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome,” Journal of Gene Medicine, vol. 5, no. 12, pp. 1028–1038, 2003.
- E. Mansilla, G. H. Marín, H. Drago et al., “Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine,” Transplantation Proceedings, vol. 38, no. 3, pp. 967–969, 2006.
- H. Hemeda, M. Jakob, A. K. Ludwig, B. Giebel, S. Lang, and S. Brandau, “Interferon-γ and tumor necrosis factor-α differentially affect cytokine expression and migration properties of mesenchymal stem cells,” Stem Cells and Development, vol. 19, no. 5, pp. 693–706, 2010.
- N. Barbarroja, R. López-Pedrera, M. D. Mayas et al., “The obese healthy paradox: is inflammation the answer?” Biochemical Journal, vol. 430, no. 1, pp. 141–149, 2010.
- A. A. Rizvi, “Hypertension, obesity, and inflammation: the complex designs of a deadly trio,” Metabolic Syndrome and Related Disorders, vol. 8, no. 4, pp. 287–294, 2010.
- B. G. Gálvez, N. San Martín, and C. Rodríguez, “TNF-alpha is required for the attraction of mesenchymal precursors to white adipose tissue in Ob/ob mice,” PLoS One, vol. 4, no. 2, article e4444, 2009.
- M. J. Peterson, M. C. Morey, C. Giuliani et al., “Walking in old age and development of metabolic syndrome: the health, aging, and body composition study,” Metabolic Syndrome and Related Disorders, vol. 8, no. 4, pp. 317–322, 2010.
- E. V. Tereshina, “Metabolic abnormalities as a basis for age-dependent diseases and aging? State of the art,” Advances in Gerontology, vol. 22, no. 1, pp. 129–138, 2009.
- J. Halaschek-Wiener and A. Brooks-Wilson, “Progeria of stem cells: stem cell exhaustion in Hutchinson-Gilford progeria syndrome,” Journals of Gerontology. Series A, vol. 62, no. 1, pp. 3–8, 2007.
- J. Mazereeuw-Hautier, L. C. Wilson, S. Mohammed et al., “Hutchinson-Gilford progeria syndrome: clinical findings in three patients carrying the G608G mutation in LMNA and review of the literature,” British Journal of Dermatology, vol. 156, no. 6, pp. 1308–1314, 2007.
- H. D. M. Coutinho, V. S. Falcão-Silva, and G. F. Gonçalves, “Hutchinson-gilford progeria syndrome: clinical and genetical traits,” Panminerva Medica, vol. 51, no. 2, pp. 134–135, 2009.
- I. Russo-Menna and C. Arancibias, “The Hutchinson-Gilford Progeria Syndrome: a case report,” Minerva Anestesiologica, vol. 76, no. 2, pp. 151–154, 2010.
- H. D. M. Coutinho, V. S. Falcão-Silva, G. Gonçalves, and R. da Nóbrega, “Molecular ageing in progeroid syndromes: Hutchinson-Gilford progeria syndrome as a model,” Immunity and Ageing, vol. 6, article no. 4, 2009.
- M. A. Merideth, L. B. Gordon, S. Clauss et al., “Phenotype and course of Hutchinson-Gilford progeria syndrome,” New England Journal of Medicine, vol. 358, no. 6, pp. 592–604, 2008.
- K. N. Dahl, P. Scaffidi, M. F. Islam, A. G. Yodh, K. L. Wilson, and T. Misteli, “Distinct structural and mechanical properties of the nuclear lamina in Hutchinson-Gilford progeria syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 27, pp. 10271–10276, 2006.
- J. Candelario, S. Sudhakar, S. Navarro, S. Reddy, and L. Comai, “Perturbation of wild-type lamin A metabolism results in a progeroid phenotype,” Aging Cell, vol. 7, no. 3, pp. 355–367, 2008.
- P. Scaffidi and T. Misteli, “Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing,” Nature Cell Biology, vol. 10, no. 4, pp. 452–459, 2008.
- J. L. V. Broers, F. C. S. Ramaekers, G. Bonne, R. Ben Yaou, and C. J. Hutchison, “Nuclear lamins: laminopathies and their role in premature ageing,” Physiological Reviews, vol. 86, no. 3, pp. 967–1008, 2006.
- E. Fuchs, “The tortoise and the hair: slow-cycling cells in the stem cell race,” Cell, vol. 137, no. 5, pp. 811–819, 2009.
- J. M. Bridger and I. R. Kill, “Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis,” Experimental Gerontology, vol. 39, no. 5, pp. 717–724, 2004.
- J. W. Hou, “Natural course of neonatal progeroid syndrome,” Pediatrics and Neonatology, vol. 50, no. 3, pp. 102–109, 2009.
- S. L. Ding and C. Y. Shen, “Model of human aging: recent findings on Werner's and Hutchinson-Gilford progeria syndromes,” Clinical Interventions in Aging, vol. 3, no. 3, pp. 431–444, 2008.
- W. B. Ershler, L. Ferrucci, and D. L. Longo, “Hutchinson-Gilford progeria syndrome,” New England Journal of Medicine, vol. 358, no. 22, pp. 2409–2410, 2008.
- B. Korf, “Focus on research: Hutchinson-Gilford progeria syndrome, aging, and the nuclear lamina,” New England Journal of Medicine, vol. 358, no. 6, pp. 552–554, 2008.
- R. S. C. Friedman and D. S. Krause, “Regeneration and repair: new findings in stem cell research and aging,” Annals of the New York Academy of Sciences, vol. 1172, pp. 88–94, 2009.
- K. E. Wellen and G. S. Hotamisligil, “Inflammation, stress, and diabetes,” Journal of Clinical Investigation, vol. 115, no. 5, pp. 1111–1119, 2005.
- B. Gustafson, A. Hammarstedt, C. X. Andersson, and U. Smith, “Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 11, pp. 2276–2283, 2007.
- I. Bellantuono, A. Aldahmash, and M. Kassem, “Aging of marrow stromal (skeletal) stem cells and their contribution to age-related bone loss,” Biochimica et Biophysica Acta, vol. 1792, no. 4, pp. 364–370, 2009.
- O. Naveiras, V. Nardi, P. L. Wenzel, P. V. Hauschka, F. Fahey, and G. Q. Daley, “Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment,” Nature, vol. 460, no. 7252, pp. 259–263, 2009.
- A. Dunac, C. Frelin, M. Popolo-Blondeau, M. Chatel, M. H. Mahagne, and P. J. M. Philip, “Neurological and functional recovery in human stroke are associated with peripheral blood CD34+ cell mobilization,” Journal of Neurology, vol. 254, no. 3, pp. 327–332, 2007.
- V. L. T. Ballard and J. M. Edelberg, “Stem cells and the regeneration of the aging cardiovascular system,” Circulation Research, vol. 100, no. 8, pp. 1116–1127, 2007.
- N. A. Mikirova, J. A. Jackson, R. Hunninghake et al., “Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects,” Journal of Translational Medicine, vol. 8, article no. 34, 2010.
- G. S. Jensen, A. N. Hart, L. A. M. Zaske et al., “Mobilization of human CD34+CD133+ and CD34+CD133- stem cells in vivo by consumption of an extract from Aphanizomenon flos-aquae-related to modulation of CXCR4 expression by an L-selectin ligand?” Cardiovascular Revascularization Medicine, vol. 8, no. 3, pp. 189–202, 2007.
- T. E. Ichim, Z. Zhong, N. A. Mikirova et al., “Circulating endothelial progenitor cells and erectile dysfunction: possibility of nutritional intervention?” Panminerva medica, vol. 52, no. 2, supplement 1, pp. 75–80, 2010.
- S. Erbs, R. Höllriegel, A. Linke et al., “Exercise training in patients with advanced chronic heart failure (NYHA IIIb) promotes restoration of peripheral vasomotor function, induction of endogenous regeneration, and improvement of left ventricular function,” Circulation: Heart Failure, vol. 3, no. 4, pp. 486–494, 2010.
- T. Kondo, M. Hayashi, K. Takeshita et al., “Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 8, pp. 1442–1447, 2004.
- C. Fiorito, M. Rienzo, E. Crimi et al., “Antioxidants increase number of progenitor endothelial cells through multiple gene expression pathways,” Free Radical Research, vol. 42, no. 8, pp. 754–762, 2008.
- L. Xia, X. X. Wang, X. S. Hu et al., “Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms,” British Journal of Pharmacology, vol. 155, no. 3, pp. 387–394, 2008.
- P. Menasché, O. Alfieri, S. Janssens et al., “The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation,” Circulation, vol. 117, no. 9, pp. 1189–1200, 2008.
- M. Yousef, C. M. Schannwell, M. Köstering, T. Zeus, M. Brehm, and B. E. Strauer, “The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction,” Journal of the American College of Cardiology, vol. 53, no. 24, pp. 2262–2269, 2009.
- J. M. Gimble, A. J. Katz, and B. A. Bunnell, “Adipose-derived stem cells for regenerative medicine,” Circulation Research, vol. 100, no. 9, pp. 1249–1260, 2007.
- J. O. Beitnes, E. Hopp, K. Lunde et al., “Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study,” Heart, vol. 95, no. 24, pp. 1983–1989, 2009.
- G. P. Meyer, K. C. Wollert, J. Lotz et al., “Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation infarct regeneration) trial,” Circulation, vol. 113, no. 10, pp. 1287–1294, 2006.
- T. T. Tran, Y. Yamamoto, S. Gesta, and C. R. Kahn, “Beneficial effects of subcutaneous fat transplantation on metabolism,” Cell Metabolism, vol. 7, no. 5, pp. 410–420, 2008.
- S. Klebanov, C. M. Astle, O. DeSimone, V. Ablamunits, and D. E. Harrison, “Adipose tissue transplantation protects ob/ob mice from obesity, normalizes insulin sensitivity and restores fertility,” Journal of Endocrinology, vol. 186, no. 1, pp. 203–211, 2005.
- S. R. Coleman, “Long-term survival of fat transplants: controlled demonstrations,” Aesthetic Plastic Surgery, vol. 19, no. 5, pp. 421–425, 1995.
- P. Bauer-Kreisel, A. Goepferich, and T. Blunk, “Cell-delivery therapeutics for adipose tissue regeneration,” Advanced Drug Delivery Reviews, vol. 62, no. 7-8, pp. 798–813, 2010.
- S. Caspar-Bauguil, B. Cousin, A. Galinier et al., “Adipose tissues as an ancestral immune organ: site-specific change in obesity,” FEBS Letters, vol. 579, no. 17, pp. 3487–3492, 2005.
- B. Puissant, C. Barreau, P. Bourin et al., “Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells,” British Journal of Haematology, vol. 129, no. 1, pp. 118–129, 2005.
- R. Yañez, M. L. Lamana, J. García-Castro, I. Colmenero, M. Ramírez, and J. A. Bueren, “Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease,” Stem Cells, vol. 24, no. 11, pp. 2582–2591, 2006.
- K. Le Blanc and O. Ringdén, “Immunomodulation by mesenchymal stem cells and clinical experience,” Journal of Internal Medicine, vol. 262, no. 5, pp. 509–525, 2007.
- K. Yoshimura, K. Sato, N. Aoi, M. Kurita, T. Hirohi, and K. Harii, “Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells,” Aesthetic Plastic Surgery, vol. 32, no. 1, pp. 48–55, 2008.
- E. L. Lacy and T. J. Bartness, “Effects of white adipose tissue grafts on total body fat and cellularity are dependent on graft type and location,” American Journal of Physiology, vol. 289, no. 2, pp. R380–R388, 2005.
- G. Dellagiacoma, A. Sbarbati, M. Rossi et al., “Brown adipose tissue: magnetic resonance imaging and ultrastructural studies after transplantation in syngeneic rats,” Transplantation Proceedings, vol. 24, no. 6, p. 2986, 1992.
- L. Ferren, “Morphological differentiation of implanted brown and white fats,” Transactions of the Kansas Academy of Science, vol. 69, no. 1, pp. 350–353, 1966.
- A. Garg and A. K. Agarwal, “Lipodystrophies: disorders of adipose tissue biology,” Biochimica et Biophysica Acta, vol. 1791, no. 6, pp. 507–513, 2009.
- O. Gavrilova, B. Marcus-Samuels, D. Graham et al., “Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice,” Journal of Clinical Investigation, vol. 105, no. 3, pp. 271–278, 2000.
- D. M. Huffman and N. Barzilai, “Role of visceral adipose tissue in aging,” Biochimica et Biophysica Acta, vol. 1790, no. 10, pp. 1117–1123, 2009.
- R. Muzumdar, D. B. Allison, D. M. Huffman et al., “Visceral adipose tissue modulates mammalian longevity,” Aging Cell, vol. 7, no. 3, pp. 438–440, 2008.
- D. M. Huffman and N. Barzilai, “Contribution of adipose tissue to health span and longevity,” Interdisciplinary Topics in Gerontology, vol. 37, pp. 1–19, 2010.